Zentalis Pharmaceuticals ZNTL
NASDAQ ZNTL
$1.91 +0.12 (+6.39%)
As of: Nov 11, 2026 · 10:22 AM EST

Zentalis Pharmaceuticals (ZNTL) Preferred Stock Liabilities (2019 - 2020)

Updated

Zentalis Pharmaceuticals (ZNTL) recorded Preferred Stock Liabilities of $155.93 million in Q1 2020, up 10.0% from the prior quarter.

Analysis

Zentalis Pharmaceuticals (ZNTL) Preferred Stock Liabilities (2019 - 2020) Analysis & Trends

At the end of FY2019, Zentalis Pharmaceuticals reported Preferred Stock Liabilities of $141.71 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Zentalis Pharmaceuticals 176.87 Mn -684.28 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 155.93 Mn
Dec 31, 2019 141.71 Mn
Sep 30, 2019 141.71 Mn
API Access

Zentalis Pharmaceuticals Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=ZNTL&period=max&api_key=YOUR_API_KEY